publications

Research should be for everyone. Can't access one of my papers? Email me!

2024

  1. Technology transfer, intellectual property, and the fight for the soul of WHO
    Melissa Barber
    PLOS Global Public Health, Dec 2024
    DOI HTML PDF
  2. To get a fair deal on Wegovy, buying Novo Nordisk might not be Medicare’s worst option
    Melissa Barber, Joseph S. Ross, and Reshma Ramachandran
    STAT News, Jul 2024
    HTML
  3. Integrating Equity Into Licensing Agreements for Taxpayer-Funded Technologies
    Jishian Ravinthiran, Bryce Robinson, Peter Maybarduk, Rachel M. Cohen, Pascale Boulet, Michelle Childs, Mihir Mankad, Isabel Parkey, James Love, Melissa Barber, and Brook Baker
    Health Affairs Forefront, Dec 2024
    DOI HTML
  4. Counting On Insulin Manufacturers To Do The Right Thing Is Not A Good Policy Prescription To Avert Shortages
    Melissa Barber, Athena Sofides, and Reshma Ramachandran
    Health Affairs Forefront, Jul 2024
    DOI HTML
  5. Estimated Sustainable Cost-Based Prices for Diabetes
    Melissa J Barber, Dzintars Gotham, Helen Bygrave, and Christa Cepuch
    JAMA Network Open, Mar 2024
    DOI HTML PDF
  6. Estimating The Effects Of COVID-19 On Globalized Markets For Active Pharmaceutical Ingredients
    Melissa Barber, Reshma Ramachandran, and Suerie Moon
    Health Affairs, Jul 2024
    DOI HTML

2023

  1. Access to NCD Medicines: Emergent Issues During the COVID-19 Pandemic and Key Structural Factors
    Jul 2023
    HTML PDF

2022

  1. A strategy that gives half of the world a discount on COVID-19 antivirals, but keeps a firm grip on power
    Melissa Barber
    PLOS Global Public Health, May 2022
    DOI HTML PDF
  2. Under Pressure: Strategies to improve access to medicines to treat high blood pressure in low- and middle-income countries
    May 2022
    PDF

2021

  1. COVID-19 antivirals must not affect HIV drug supply
    Melissa Barber, Ameet Sarpatwari, and Christa Cepuch
    The Lancet HIV, Jan 2021
    DOI HTML PDF

2020

  1. Price of a hepatitis C cure: Cost of production and current prices for direct-acting antivirals in 50 countries
    Melissa J Barber, Dzintars Gotham, Giten Khwairakpam, and Andrew Hill
    Journal of Virus Eradication, Sep 2020
    DOI HTML PDF
  2. How a US-UK trade agreement could affect NHS drug prices
    Dzintars Gotham, Melissa J Barber, and Andrew M Hill
    BMJ, Jun 2020
    DOI HTML PDF

2019

  1. Estimation of cost-based prices for injectable medicines in the WHO Essential Medicines List
    Dzintars Gotham, Melissa J Barber, and Andrew Hill
    BMJ Open, Sep 2019
    DOI HTML PDF
  2. Global access of rifabutin for the treatment of tuberculosis–why should we prioritize this
    N Rockwood, M Cerrone, M Barber, A Hill, and A. Pozniak
    Journal of the International AIDS Society, Jul 2019
    DOI HTML PDF
  3. Improving affordability of new essential cancer medicines
    Ellen Hoen, Salome Meyer, Patrick Durisch, Wilbert Bannenberg, Katrina Perehudoff, Timothy Reed, and Melissa Barber
    The Lancet Oncology, Jan 2019
    DOI HTML PDF
  4. Pulling Together to Beat Superbugs: Knowledge and Implementation Gaps in Addressing Antimicrobial Resistance
    Jan 2019
    HTML PDF

2018

  1. Estimated costs of production and potential prices for the WHO Essential Medicines List
    Dzintars Gotham, Melissa J Barber, and Andrew Hill
    BMJ Global Health, Jan 2018
    DOI HTML PDF
  2. Production costs and potential prices for biosimilars of human insulin and insulin analogues
    Dzintars Gotham, Melissa J Barber, and Andrew Hill
    BMJ Global Health, Sep 2018
    DOI HTML PDF

2017

  1. Youth demand action on the shared global challenge of access to medicines
    Lancet Youth Commission Essential Medicines Policies
    The Lancet Global Health, Jan 2017
    DOI HTML PDF

2016

  1. Open letter to the candidates for Director-General of the World Health Organization: Will you support an R&D agreement that puts patient needs at the centre of R&D?
    Melissa J Barber, Dzintars Gotham, Julia Muntanya, and Thiru Balasubramanian
    The Lancet Global Health, Dec 2016
    DOI HTML PDF
  2. How the MDGs gave up on measuring access to medicines
    Dzintars Gotham, Melissa J Barber, and Kristine Onarheim
    The Lancet Global Health, May 2016
    DOI HTML PDF
  3. Lancet Youth Commission on Essential Medicines Policies
    Nov 2016